Modern Drug House — Insulin Exporter Profile
Indian Pharmaceutical Exporter · #7 for Insulin · $1.1M export value · DGFT Verified
Modern Drug House is the #7 Indian exporter of Insulin with $1.1M in export value and 72 verified shipments. Modern Drug House holds a 1.5% market share in Insulin exports across 2 countries. The company exports 5 pharmaceutical products worth $1.7M across 4 therapeutic categories.
Modern Drug House — Insulin Export Profile: Buyers & Destinations
Where Does Modern Drug House Export Insulin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SAUDI ARABIA | $1.0M | 39 | 99.1% |
| SIERRA LEONA | $7.1K | 21 | 0.7% |
| SIERRA LEONE | $2.5K | 12 | 0.2% |
Modern Drug House exports Insulin to 3 countries. The largest destination is SAUDI ARABIA accounting for 99.1% of Modern Drug House's Insulin shipments, followed by SIERRA LEONA (0.7%) and SIERRA LEONE (0.2%). These destinations reflect Modern Drug House's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Insulin from Modern Drug House?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF- | SAUDI ARABIA | $832.2K | 41 |
| TO THE ORDER OF | SIERRA LEONA | $215.4K | 14 |
| TO THE ORDER OF, | SIERRA LEONA | $5.1K | 13 |
| AFRICAN SURGICAL | SIERRA LEONE | $753 | 2 |
| TO THE ORDER | SIERRA LEONE | $408 | 2 |
Modern Drug House supplies Insulin to 5 buyers globally. The largest buyer is TO THE ORDER OF- (SAUDI ARABIA), followed by TO THE ORDER OF (SIERRA LEONA) and TO THE ORDER OF, (SIERRA LEONA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Insulin Export Value and How Much Does Modern Drug House Contribute?
India exported $52.4M worth of Insulin through 2,532 shipments from 188 suppliers to 111 countries, serving 384 buyers globally. Modern Drug House contributes $1.1M to this total, accounting for 1.5% of India's Insulin exports. Modern Drug House ships Insulin to 3 countries through 5 buyers.
What Is the Average Shipment Value for Modern Drug House's Insulin Exports?
Modern Drug House's average Insulin shipment value is $15.6K per consignment, based on 72 shipments totaling $1.1M. The largest destination is SAUDI ARABIA (99.1% of Modern Drug House's Insulin exports).
How Does Modern Drug House Compare to Other Indian Insulin Exporters?
Modern Drug House ranks #7 among 188 Indian Insulin exporters with a 1.5% market share. The top 3 exporters are WOCKHARDT LIMITED ($22.7M), M. J. BIOPHARM PRIVATE LIMITED ($15.2M), GLAND PHARMA LTD ($4.0M). Modern Drug House processed 72 shipments to 2 destination countries.
What Insulin Formulations Does Modern Drug House Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION(25% INSULINLISPRO AND 75% INSULIN LISPRO INJ, 3ML P | $404.0K | 11 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION 25 INSULINLISPRO AND 75 INSULIN LISPRO INJ 3ML P | $127.2K | 4 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION (25% INSULINLISPRO AND 75% INSULIN LISPRO INJ, 3ML | $106.9K | 5 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION 25 INSULINLISPRO AND 75 INSULIN LISPRO INJ 3ML | $86.4K | 4 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO IP 3ML SOLUTION FOR INJECTION IN PREFILLED PEN 100IU/ML BRAND: HUMALOG | $75.1K | 4 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION (25% INSULIN LISPRO AND 75% INSULIN LISPRO INJ, 3ML | $60.4K | 2 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION (50% INSULINLISPRO AND 50% INSULIN LISPRO INJ, 3ML | $57.8K | 3 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO IP 3ML SOLUTION FOR INJECTION IN PREFILLED PEN 100IU/ML (HUMALOG KWIKPE | $40.4K | 2 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC INJECTION(25% INSULINLISPRO AND 75% INSULIN LISPRO INJ, 3ML | $38.0K | 1 |
| PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO IP 3ML SOLUTION FOR INJECTION IN PREFILLED PEN 100IU/ML BRAND: HUMALOG | $23.9K | 1 |
Modern Drug House exports 29 distinct Insulin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL HARMLESS MEDICINES INSULIN LISPRO BIPHASIC IN with 11 shipments worth $404.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Modern Drug House Compare to Nearest Insulin Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | M J BIOPHARM PRIVATE LIMITED | $3.8M | 75 | 15 | $50.0K |
| 5 | ANGEL BIOGENICS PRIVATE LIMITED | $1.7M | 47 | 4 | $35.9K |
| 7 | MODERN DRUG HOUSE ★ | $1.1M | 72 | 2 | $15.6K |
| 9 | TIMES MEDICAMENT PRIVATE LIMITED | $913.8K | 20 | 1 | $45.7K |
| 10 | SANOFI INDIA LIMITED | $640.4K | 16 | 2 | $40.0K |
Modern Drug House ranks #7 among 188 Indian Insulin exporters. Average shipment value of $15.6K compared to the market average of $278.5K. The closest competitors by value are M J BIOPHARM PRIVATE LIMITED and ANGEL BIOGENICS PRIVATE LIMITED.
Which Indian Ports Ship Insulin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 704 | 27.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 646 | 25.5% |
| Bombay Air | 177 | 7.0% |
| Bombay Air Cargo | 123 | 4.9% |
| NHAVA SHEVA SEA (INNSA1) | 108 | 4.3% |
| DELHI AIR | 76 | 3.0% |
| BANGALORE ACC (INBLR4) | 69 | 2.7% |
| JNPT | 68 | 2.7% |
About Modern Drug House
Modern Drug House exports 5 products worth $1.7M. Beyond Insulin, top products include Cyclosporine, Plasma, Antitoxin, Nivolumab. View the complete Modern Drug House profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Insulin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Insulin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Modern Drug House matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 72 individual customs records matching Modern Drug House exporting Insulin, covering 29 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 111+ countries, 384+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Insulin Export Data from Modern Drug House
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Modern Drug House's Insulin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Modern Drug House
Full Company Profile →
5 products · $1.7M total trade · 4 categories
Insulin Stats
Company Overview
Top Products by Modern Drug House
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Modern Drug House.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Insulin. For current shipment-level data, contact TransData Nexus.